Document is current
Any future updates will be listed below
-
Authors
Linkov, Faina https://orcid.org/0000-0002-3707-0104
Chang, Yue-Fang https://orcid.org/0000-0003-0080-4597
Ramanan, Harshitha https://orcid.org/0009-0009-4525-8359
Morgan, Richard S. https://orcid.org/0009-0003-1800-8545
McTigue, Kathleen M. https://orcid.org/0000-0002-0752-1576
Dimmock, Anne E. F. https://orcid.org/0000-0002-9422-7745
Bascom, Rebecca https://orcid.org/0000-0001-5875-3476
Kass, Daniel J. https://orcid.org/0000-0001-6597-7830
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 22 February 2025
First Online: 10 March 2025
Declarations
:
: University of Pittsburgh IRB # STUDY19080231 (exempt as non-human subject research). Penn State University IRB #STUDY00017636 (exempt as non-human subject research).
: Not applicable.
: This was an independent, investigator initiated study supported by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI). BIPI had no role in the design, analysis or interpretation of the results in this study; BIPI was given the opportunity to review the manuscript for medical and scientific accuracy as it relates to BIPI substances, as well as intellectual property consideration.
